Toxidromes: Clinical Features

Toxidromes are distinct symptom patterns that signal drug or chemical overdose, enabling rapid diagnosis and treatment. Recognition of these patterns is critical for healthcare providers to manage poisoning effectively and initiate appropriate pharmaceutical poisoning treatment strategies quickly.

Anticholinergic toxidrome results from muscarinic receptor inhibition and parasympathetic suppression. Clinical features include dry flushed skin, hyperthermia, mydriasis (dilated pupils), delirium, and reduced intestinal motility. Drugs like atropine and diphenhydramine commonly cause this pattern.

Cholinergic toxidrome occurs when agents inhibit acetylcholinesterase, causing acetylcholine accumulation and muscarinic overstimulation. Symptoms include somnolence, coma, miosis (constricted pupils), excessive salivation, diarrhea, gastric cramping, emesis, and muscle twitching. Organophosphates are a common cause.

Sympathomimetic toxidrome results from sympathetic nervous system stimulation, producing agitation, hypertension, tachycardia, mydriasis, tremors, sweating, and hyperthermia. Cocaine and amphetamines commonly cause this pattern, which contrasts with depressant toxidromes that reduce vital signs.

Opioid overdose suppresses the central nervous system, typically causing miosis, respiratory depression, bradycardia, and reduced gut motility. These effects result from opioid receptor activation and can rapidly become life-threatening if not treated promptly.

Sedatives and hypnotics depress central nervous system activity, causing drowsiness, respiratory depression, and diminished reflexes. Benzodiazepines and barbiturates are common examples that produce this depressant toxidrome pattern affecting multiple organ systems.

The six most common toxidromes are anticholinergic, cholinergic, opioid, sympathomimetic, sedative-hypnotic, and salicylate. Each produces a distinct symptom cluster reflecting the drug class's mechanism of action on the nervous system and vital functions.